Terbequinil

Terbequinil

Clinical data
ATC code	none
Identifiers
IUPAC name 1-(methoxymethyl)-4-oxo-N-propylquinoline-3-carboxamide
CAS Number	113079-82-6  N
PubChem CID	65916
ChemSpider	59325  Y
UNII	0DH9WUS03O
CompTox Dashboard (EPA)	DTXSID50150281
Chemical and physical data
Formula	C15H18N2O3
Molar mass	274.320 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCNC(=O)C1=CN(C2=CC=CC=C2C1=O)COC
InChI InChI=1S/C15H18N2O3/c1-3-8-16-15(19)12-9-17(10-20-2)13-7-5-4-6-11(13)14(12)18/h4-7,9H,3,8,10H2,1-2H3,(H,16,19) Y Key:RIPDGZHPNKQLDC-UHFFFAOYSA-N Y
NY  (what is this?)    (verify)

Terbequinil (SR-25776) is an experimental chemical compound that has been investigated for modulation of the [[GABA_A receptor]]. Public drug and chemistry databases describe it as a quinoline derivative with carboxamide and ether functional groups. ^{[1] [2]}

The compound has been the subject of preclinical and early clinical investigations but is **not approved** for medical use and has no active marketed indications. ^{[3] [4]}

See also

• GABAA receptor negative allosteric modulator

References

1. "Terbequinil (SR-25776)". PubChem. Retrieved 14 October 2025.
2. "Terbequinil". NCATS Inxight Drugs. Retrieved 14 October 2025.
3. "Terbequinil". AdisInsight. Springer Nature. Retrieved 14 October 2025.
4. "Terbequinil (SR-25776) — chemical structure". ChemSpider. Retrieved 14 October 2025.